• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型和 2 型糖尿病中的肥胖症和肾脏疾病:国家糖尿病审计分析。

Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit.

机构信息

Centre for Public Health, Institute of Clinical Sciences Block B, Queen's University Belfast, Royal Victoria Hospital, Grosvenor Road, Belfast BT12 6BA, UK.

出版信息

QJM. 2013 Oct;106(10):933-42. doi: 10.1093/qjmed/hct123. Epub 2013 May 20.

DOI:10.1093/qjmed/hct123
PMID:23696677
Abstract

BACKGROUND

Obesity is increasingly prevalent in many countries. Obesity is a major risk factor for the development of type 2 diabetes but its relationship with diabetic kidney disease (DKD) remains unclear. Some studies have suggested that the metabolic syndrome (including obesity) may be associated with DKD in type 1 diabetes.

AIM

To investigate the association between obesity and DKD.

DESIGN

Retrospective cross-sectional study.

METHODS

National Diabetes Audit data were available for the 2007-08 cycle. Type 1 and 2 diabetes patients with both a valid serum creatinine and urinary albumin:creatinine ratio were included. DKD was defined as an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m(2), albuminuria or both. Logistic regression was used to analyse associations of obesity (body mass index ≥30 kg/m(2)) and other variables including year of birth, year of diagnosis, ethnicity and stage of kidney disease.

RESULTS

A total of 58 791 type 1 and 733 769 type 2 diabetes patients were included in the analysis. After adjustment, when compared with type 1 diabetes patients with normal renal function those with DKD were up to twice as likely to be obese. Type 2 DKD patients were also more likely to be obese. For example, type 2 diabetes patients with an eGFR <15 ml/min/1.73 m(2) and normoalbuminuria, microalbuminuria or macroalbuminuria were all more likely to be obese; odds ratios (95% CI) 1.65 (1.3-2.1), 1.56 (1.28-1.92) and 1.27 (1.05-1.54), respectively.

CONCLUSION

This study has highlighted a strong association between obesity and kidney disease in type 1 diabetes and confirmed their association in type 2 diabetes.

摘要

背景

肥胖在许多国家越来越普遍。肥胖是 2 型糖尿病发展的主要危险因素,但它与糖尿病肾病(DKD)的关系尚不清楚。一些研究表明,代谢综合征(包括肥胖)可能与 1 型糖尿病的 DKD 有关。

目的

研究肥胖与 DKD 的关系。

设计

回顾性横断面研究。

方法

可获得 2007-08 年周期的国家糖尿病审计数据。纳入同时有有效血清肌酐和尿白蛋白/肌酐比值的 1 型和 2 型糖尿病患者。DKD 的定义为估计肾小球滤过率(eGFR)<60ml/min/1.73m2、白蛋白尿或两者兼有。使用 logistic 回归分析肥胖(体重指数≥30kg/m2)和其他变量(包括出生年份、诊断年份、种族和肾病阶段)与 DKD 的关联。

结果

共纳入 58791 例 1 型和 733769 例 2 型糖尿病患者。调整后,与肾功能正常的 1 型糖尿病患者相比,DKD 患者肥胖的可能性高达两倍。2 型 DKD 患者也更有可能肥胖。例如,eGFR<15ml/min/1.73m2 且无白蛋白尿、微量白蛋白尿或大量白蛋白尿的 2 型糖尿病患者均更有可能肥胖;比值比(95%CI)分别为 1.65(1.3-2.1)、1.56(1.28-1.92)和 1.27(1.05-1.54)。

结论

本研究强调了肥胖与 1 型糖尿病患者肾病之间的强烈关联,并证实了其与 2 型糖尿病患者肾病之间的关联。

相似文献

1
Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit.1 型和 2 型糖尿病中的肥胖症和肾脏疾病:国家糖尿病审计分析。
QJM. 2013 Oct;106(10):933-42. doi: 10.1093/qjmed/hct123. Epub 2013 May 20.
2
Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018.系统免疫炎症指数与 2 型糖尿病患者的糖尿病肾脏疾病相关:来自 NHANES 2011-2018 的证据。
Front Endocrinol (Lausanne). 2022 Dec 6;13:1071465. doi: 10.3389/fendo.2022.1071465. eCollection 2022.
3
Chronic kidney disease and diabetes in the national health service: a cross-sectional survey of the U.K. national diabetes audit.英国国家糖尿病审计中全国卫生服务体系中的慢性肾脏病和糖尿病:横断面调查。
Diabet Med. 2014 Apr;31(4):448-54. doi: 10.1111/dme.12312. Epub 2013 Oct 1.
4
Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study.中性粒细胞与淋巴细胞比值与 2 型糖尿病患者糖尿病肾病的关系:一项横断面研究。
Front Endocrinol (Lausanne). 2024 Jan 4;14:1285509. doi: 10.3389/fendo.2023.1285509. eCollection 2023.
5
The Relationship between Generalized and Abdominal Obesity with Diabetic Kidney Disease in Type 2 Diabetes: A Multiethnic Asian Study and Meta-Analysis.2 型糖尿病中全身性和腹部肥胖与糖尿病肾病的关系:一项多民族亚洲研究和荟萃分析。
Nutrients. 2018 Nov 5;10(11):1685. doi: 10.3390/nu10111685.
6
Genetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.肥胖在糖尿病肾病中起因果作用的遗传学证据。
Diabetes. 2015 Dec;64(12):4238-46. doi: 10.2337/db15-0254. Epub 2015 Aug 25.
7
Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.非白蛋白尿性糖尿病肾病与 2 型糖尿病全因死亡率及心血管和肾脏结局的关系:来自香港糖尿病生物库的研究结果。
Am J Kidney Dis. 2022 Aug;80(2):196-206.e1. doi: 10.1053/j.ajkd.2021.11.011. Epub 2022 Jan 6.
8
Metabolic Syndrome Rather than Obesity Alone Is More Significant for Kidney Disease.代谢综合征比单纯肥胖对肾脏疾病更重要。
Obes Surg. 2019 Nov;29(11):3478-3483. doi: 10.1007/s11695-019-04011-2.
9
Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetes.比较日本 1 型和 2 型糖尿病患者慢性肾脏病的患病率。
Diabet Med. 2010 Sep;27(9):1017-23. doi: 10.1111/j.1464-5491.2010.03049.x.
10
Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus.肥胖相关指标与2型糖尿病患者的蛋白尿及晚期肾病相关。
Ren Fail. 2021 Dec;43(1):1250-1258. doi: 10.1080/0886022X.2021.1969247.

引用本文的文献

1
Trends and Disparities in the Burden of Chronic Kidney Disease due to Type 2 Diabetes in China From 1990 to 2021: A Population-Based Study.1990年至2021年中国2型糖尿病所致慢性肾脏病负担的趋势与差异:一项基于人群的研究
J Diabetes. 2025 Apr;17(4):e70084. doi: 10.1111/1753-0407.70084.
2
Comprehending the Role of Metabolic and Hemodynamic Factors Alongside Different Signaling Pathways in the Pathogenesis of Diabetic Nephropathy.理解代谢和血流动力学因素以及不同信号通路在糖尿病肾病发病机制中的作用。
Int J Mol Sci. 2025 Apr 3;26(7):3330. doi: 10.3390/ijms26073330.
3
Global Burden of Type 1 Diabetes Mellitus Related Chronic Kidney Disease among Adolescents and Young Adults, and Projections to 2035: Results from the Global Burden of Disease Study 2021.
青少年和青年中1型糖尿病相关慢性肾脏病的全球负担及到2035年的预测:全球疾病负担研究2021的结果
Diabetes Metab J. 2025 Jul;49(4):812-825. doi: 10.4093/dmj.2024.0544. Epub 2025 Mar 10.
4
Trends in obesity and glucagon-like peptide-1 receptor agonist prescriptions in type 1 diabetes in the United States.美国1型糖尿病患者肥胖及胰高血糖素样肽-1受体激动剂处方的趋势
Diabetes Obes Metab. 2025 Jun;27(6):2967-2976. doi: 10.1111/dom.16300. Epub 2025 Mar 3.
5
Determinants of Liraglutide Treatment Discontinuation in Type 1 Diabetes: A Post Hoc Analysis of ADJUNCT ONE and ADJUNCT TWO Randomized Placebo-Controlled Clinical Studies.1型糖尿病中利拉鲁肽治疗中断的决定因素:ADJUNCT ONE和ADJUNCT TWO随机安慰剂对照临床研究的事后分析
J Diabetes Sci Technol. 2025 Mar;19(2):321-331. doi: 10.1177/19322968241305647. Epub 2024 Dec 24.
6
Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial.地中海饮食作为 2 型糖尿病合并肥胖症冠心病患者保护肾功能的策略:CORDIOPREV 随机对照试验的二次分析。
Nutr Diabetes. 2024 May 16;14(1):27. doi: 10.1038/s41387-024-00285-3.
7
Epidemiological patterns of chronic kidney disease attributed to type 2 diabetes from 1990-2019.1990-2019 年归因于 2 型糖尿病的慢性肾脏病的流行病学模式。
Front Endocrinol (Lausanne). 2024 Apr 17;15:1383777. doi: 10.3389/fendo.2024.1383777. eCollection 2024.
8
The therapeutic effect of mesenchymal stem cells in diabetic kidney disease.间充质干细胞在糖尿病肾病中的治疗效果。
J Mol Med (Berl). 2024 Apr;102(4):537-570. doi: 10.1007/s00109-024-02432-w. Epub 2024 Feb 29.
9
Global burden and influencing factors of chronic kidney disease due to type 2 diabetes in adults aged 20-59 years, 1990-2019.20-59 岁成年人 2019 年全球范围内归因于 2 型糖尿病的慢性肾脏病的负担及影响因素。
Sci Rep. 2023 Nov 19;13(1):20234. doi: 10.1038/s41598-023-47091-y.
10
Can type 1 diabetes be an unexpected complication of obesity?1 型糖尿病会是肥胖的意外并发症吗?
Front Endocrinol (Lausanne). 2023 Mar 31;14:1121303. doi: 10.3389/fendo.2023.1121303. eCollection 2023.